Fineline Cube

Follow:
14446 Articles
CompanyDrug

HutchMed’s HMPL-306 Advances to Phase III Trial in R/R AML Patients

CompanyDrug

Zai Lab’s ROS1 Inhibitor Augtyro Earns NMPA Nod for Advanced NSCLC Treatment

CompanyDrug

NMPA Accepts Jiangsu Yahong Meditech’s Application for Cervical HSIL Treatment Cevira

CompanyDrug

Mabwell’s 9MW2821 ADC for Triple Negative Breast Cancer Accepted for Review by NMPA

CompanyDrug

Huadong Medicine’s EGFR Inhibitor Mefatinib for NSCLC Accepted by NMPA for Review

CompanyDeals

Subtle Medical Inc Closes USD 10 Million Series B+ Round to Accelerate Global Expansion

CompanyDrug

Shenzhen Hepalink’s Enoxaparin Sodium Gets Green Light in Singapore

Policy / Regulatory

NMPA Updates In Vitro Diagnostic Reagents Classification List for Enhanced Regulatory Oversigh

CompanyDeals

Novartis Inks Deal to Acquire Mariana Oncology, Bolstering Radioligand Therapy Portfolio

Policy / Regulatory

China’s NMPA Revamps Medical Device Classification Rules to Improve Regulatory Efficiency

CompanyDrug

BMS’s Opdivo/Yervoy Combo Misses PFS Endpoint in Unresectable Stage III NSCLC Trial

CompanyDrug

FDA Reviews BMS’ Opdivo Subcutaneous Formulation for Broad Indications